NeuroQuest

NeuroQuest is developing a simple blood test for early diagnosis of Alzheimer’s disease.

Founded 2009
Stage Business development
Investors The Trendlines Group, InterTech Group, South Carolina Research Authority, SC Launch, Maryland-Israel Trendlines Fund
Chairman Etai Gilboa, PhD

Trendlines’ directors: Todd Dollinger, Steve Rhodes